Penn Pharmaceutical Service is categorized under Services (Unclassified) in Warrington, PA and active since 2009.
Penn Pharmaceutical Service was established in 2009, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Services (Unclassified) business, which does work in the B2B market, and is classified as a Services (Unclassified), under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Paul Wituschek at the company’s single location by writing to 1546 East Cobblestone Circle, Warrington, Pennsylvania PA 18976 or by phoning (610) 701-0980. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Penn Pharmaceutical Service |
Contact Person: | Paul Wituschek |
Address: | 1546 East Cobblestone Circle, Warrington, Pennsylvania 18976 |
Phone Number: | (610) 701-0980 |
Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
Founded: | 2009 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Services (Unclassified) |
SIC Code: | 8999 |
NAICS Code: | 4242101 |
Share This Business: |
Penn Pharmaceutical Service was started in 2009 to provide professional Services (Unclassified) under the SIC code 8999 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Paul Wituschek for inquiries that concern Penn Pharmaceutical Service by calling the company number (610) 701-0980, as your correspondence is most welcome. Additionally, the physical location of the single location of Penn Pharmaceutical Service can be found at the coordinates 40.256472,-75.12322 as well as the street address 1546 East Cobblestone Circle in Warrington, Pennsylvania 18976.
For its online presence, you may visit Penn Pharmaceutical Service’s website at and engage with its social media outlets through on Twitter and on Facebook.